These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14573669)

  • 1. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
    Gil-Lamaignere C; Roilides E; Lyman CA; Simitsopoulou M; Stergiopoulou T; Maloukou A; Walsh TJ
    Infect Immun; 2003 Nov; 71(11):6472-8. PubMed ID: 14573669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human phagocytic cell responses to Scedosporium prolificans.
    Gil-Lamaignere C; Maloukou A; Rodriguez-Tudela JL; Roilides E
    Med Mycol; 2001 Apr; 39(2):169-75. PubMed ID: 11346264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells.
    Mina S; Staerck C; d'Almeida SM; Marot A; Delneste Y; Calenda A; Tabiasco J; Bouchara JP; Fleury MJJ
    Fungal Biol; 2015 Dec; 119(12):1322-1333. PubMed ID: 26615753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp.
    Gil-Lamaignere C; Winn RM; Simitsopoulou M; Maloukou A; Walsh TJ; Roilides E
    Med Mycol; 2005 May; 43(3):253-60. PubMed ID: 16010852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
    Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
    J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
    Zeng J; Kamei K; Zheng Y; Nishimura K
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
    Winn RM; Gil-Lamaignere C; Roilides E; Simitsopoulou M; Lyman CA; Maloukou A; Walsh TJ
    Cytokine; 2005 Jul; 31(1):1-8. PubMed ID: 15935692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.
    Roilides E; Dimitriadou-Georgiadou A; Sein T; Kadiltsoglou I; Walsh TJ
    Infect Immun; 1998 Dec; 66(12):5999-6003. PubMed ID: 9826384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
    Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
    J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
    Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
    J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.
    Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):868-73. PubMed ID: 16495244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of human polymorphonuclear and mononuclear phagocytes against non-fumigatus Aspergillus species.
    Akpogheneta O; Gil-Lamaignere C; Maloukou A; Roilides E;
    Mycoses; 2003 Apr; 46(3-4):77-83. PubMed ID: 12870194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions.
    Rollin-Pinheiro R; Liporagi-Lopes LC; de Meirelles JV; Souza LM; Barreto-Bergter E
    PLoS One; 2014; 9(5):e98149. PubMed ID: 24878570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scedosporium apiospermum keratitis treated with itraconazole.
    Saracli MA; Erdem U; Gonlum A; Yildiran ST
    Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scedosporium apiospermum fungemia in a lung transplant recipient.
    Raj R; Frost AE
    Chest; 2002 May; 121(5):1714-6. PubMed ID: 12006471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis.
    Tadros TS; Workowski KA; Siegel RJ; Hunter S; Schwartz DA
    Hum Pathol; 1998 Nov; 29(11):1266-72. PubMed ID: 9824105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility and diversity in the therapy-refractory genus scedosporium.
    Lackner M; Hagen F; Meis JF; Gerrits van den Ende AH; Vu D; Robert V; Fritz J; Moussa TA; de Hoog GS
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5877-85. PubMed ID: 25070092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Scedosporium apiospermum Infection with Pulmonary Tumorlet in an Immunocompetent Patient.
    Motokawa N; Miyazaki T; Hara A; Fukuda Y; Morino S; Nakamura H; Iwasaki K; Soda H; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Kohno S; Mukae H
    Intern Med; 2018 Dec; 57(23):3485-3490. PubMed ID: 30101932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
    Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
    J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.